NAD+ 1000mg & Retatrutide - A UK News
The recent landscape of metabolic health in the UK is seeing increasing interest in the synergy of high-dose NAD+ supplementation – often at 1g dosage – and the novel GLP-1 receptor agonist Retatrutide (or its related Tirzepatide). Researchers are studying potential benefits regarding metabolic r